135 related articles for article (PubMed ID: 11681595)
1. Toward a molecular understanding of psychostimulant actions using genetically engineered dopamine receptor knockout mice as model systems.
Zhang J; Xu M
J Addict Dis; 2001; 20(3):7-18. PubMed ID: 11681595
[TBL] [Abstract][Full Text] [Related]
2. Unraveling dopamine D3 receptor function in response to psychostimulants using a genetic approach.
Xu M
Ann N Y Acad Sci; 1998 May; 844():27-39. PubMed ID: 9668662
[TBL] [Abstract][Full Text] [Related]
3. D1 dopamine receptor: a putative neurochemical and behavioral link to cocaine action.
Hummel M; Unterwald EM
J Cell Physiol; 2002 Apr; 191(1):17-27. PubMed ID: 11920678
[TBL] [Abstract][Full Text] [Related]
4. Amphetamine regulates NR2B expression in Go2α knockout mice and thereby sustains behavioral sensitization.
Brunk I; Sanchis-Segura C; Blex C; Perreau-Lenz S; Bilbao A; Spanagel R; Ahnert-Hilger G
J Neurochem; 2010 Oct; 115(1):234-46. PubMed ID: 20649838
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists.
Khroyan TV; Barrett-Larimore RL; Rowlett JK; Spealman RD
J Pharmacol Exp Ther; 2000 Aug; 294(2):680-7. PubMed ID: 10900248
[TBL] [Abstract][Full Text] [Related]
6. Characterization of behavioral response to amphetamine, tyrosine hydroxylase levels, and dopamine receptor levels in neurokinin 3 receptor knockout mice.
Nordquist RE; Savignac H; Pauly-Evers M; Walker G; Knoflach F; Borroni E; Glaentzlin P; Bohrmann B; Messer J; Ozmen L; Albientz A; Spooren W
Behav Pharmacol; 2008 Sep; 19(5-6):518-29. PubMed ID: 18690106
[TBL] [Abstract][Full Text] [Related]
7. Reduced psychostimulant effects on dopamine dynamics in the nucleus accumbens of mu-opioid receptor knockout mice.
Mathon DS; Vanderschuren LJ; Ramakers GM
Neuroscience; 2006 Sep; 141(4):1679-84. PubMed ID: 16777349
[TBL] [Abstract][Full Text] [Related]
8. Cocaine- and amphetamine-regulated transcript (CART) peptides modulate the locomotor and motivational properties of psychostimulants.
Couceyro PR; Evans C; McKinzie A; Mitchell D; Dube M; Hagshenas L; White FJ; Douglass J; Richards WG; Bannon AW
J Pharmacol Exp Ther; 2005 Dec; 315(3):1091-100. PubMed ID: 16099925
[TBL] [Abstract][Full Text] [Related]
9. The role of dopamine receptor subtypes in the discriminative stimulus effects of amphetamine and cocaine in rats.
Filip M; Przegaliński E
Pol J Pharmacol; 1997; 49(1):21-30. PubMed ID: 9431548
[TBL] [Abstract][Full Text] [Related]
10. The dopamine D4 receptor is essential for hyperactivity and impaired behavioral inhibition in a mouse model of attention deficit/hyperactivity disorder.
Avale ME; Falzone TL; Gelman DM; Low MJ; Grandy DK; Rubinstein M
Mol Psychiatry; 2004 Jul; 9(7):718-26. PubMed ID: 14699433
[TBL] [Abstract][Full Text] [Related]
11. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
Geter-Douglass B; Katz JL; Alling K; Acri JB; Witkin JM
J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
[TBL] [Abstract][Full Text] [Related]
12. Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals.
Weinshenker D; Miller NS; Blizinsky K; Laughlin ML; Palmiter RD
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13873-7. PubMed ID: 12370425
[TBL] [Abstract][Full Text] [Related]
13. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.
Rowlett JK; Platt DM; Yao WD; Spealman RD
J Pharmacol Exp Ther; 2007 Jun; 321(3):1135-43. PubMed ID: 17351103
[TBL] [Abstract][Full Text] [Related]
14. [Alteration of neuronal activities following repeated administration of stimulants].
Amano T; Matsubayashi H; Sasa M
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2002 Feb; 37(1):31-40. PubMed ID: 11915303
[TBL] [Abstract][Full Text] [Related]
15. Selective attenuation of psychostimulant-induced behavioral responses in mice lacking A(2A) adenosine receptors.
Chen JF; Beilstein M; Xu YH; Turner TJ; Moratalla R; Standaert DG; Aloyo VJ; Fink JS; Schwarzschild MA
Neuroscience; 2000; 97(1):195-204. PubMed ID: 10771351
[TBL] [Abstract][Full Text] [Related]
16. Behavioral responses to cocaine and amphetamine administration in mice lacking the dopamine D1 receptor.
Xu M; Guo Y; Vorhees CV; Zhang J
Brain Res; 2000 Jan; 852(1):198-207. PubMed ID: 10661513
[TBL] [Abstract][Full Text] [Related]
17. Long-term alterations in vulnerability to addiction to drugs of abuse and in brain gene expression after early life ethanol exposure.
Barbier E; Pierrefiche O; Vaudry D; Vaudry H; Daoust M; Naassila M
Neuropharmacology; 2008 Dec; 55(7):1199-211. PubMed ID: 18713641
[TBL] [Abstract][Full Text] [Related]
18. Effects of acute "binge" cocaine on mRNA levels of mu opioid receptor and neuropeptides in dopamine D1 or D3 receptor knockout mice.
Zhou Y; Adomako-Mensah J; Yuferov V; Ho A; Zhang J; Xu M; Kreek MJ
Synapse; 2007 Jan; 61(1):50-9. PubMed ID: 17068774
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors.
Xu M; Koeltzow TE; Santiago GT; Moratalla R; Cooper DC; Hu XT; White NM; Graybiel AM; White FJ; Tonegawa S
Neuron; 1997 Oct; 19(4):837-48. PubMed ID: 9354330
[TBL] [Abstract][Full Text] [Related]
20. Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation.
Darmopil S; Martín AB; De Diego IR; Ares S; Moratalla R
Biol Psychiatry; 2009 Sep; 66(6):603-13. PubMed ID: 19520364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
